Discovery Through Innovation Manchester Institute of Biotechnology Discovery Through Innovation Research at the Manchester Institute of Biotechnology

Total Page:16

File Type:pdf, Size:1020Kb

Discovery Through Innovation Manchester Institute of Biotechnology Discovery Through Innovation Research at the Manchester Institute of Biotechnology Discovery through Innovation Manchester Institute of Biotechnology Discovery through Innovation Research at the Manchester Institute of Biotechnology Contents Grand Challenge: Biomedical and Healthcare 43 12 Innovation in Action 45 Grand Challenge: Research Centres, Institutes and Facilities Industrial Biotechnology 48 18 Postgraduate and Training 51 Grand Challenge: Science and Society 22 Biofuels and Energy 53 Faculty Honours 57 Selected Publications Spotlight: 26 Centre for Synthetic Biology Office of the Director Nigel Scrutton Director Spotlight: Lesley-Ann Miller Communications Manager Systems Biology Rosalind Le Feuvre Research and Planning Manager 31 Penny Johnson Research Strategy Co-ordinator (EU and Industry) Janet England Support Services Manager Spotlight: Editor Lesley-Ann Miller 34 Text Mining Design & Production WeAreCreation.co.uk Spotlight: www.mib.manchester.ac.uk Technologies [email protected] 37 3 MANCHESTER INSTITUTE OF BIOTECHNOLOGY Driving discovery through innovation Fig. 1.0 Discovery through The Manchester Institute of Biotechnology inform and are informed by our research Grand Challenges and showcasing a Innovation Pipeline (MIB) is one of the leading biotechnology at the molecular, systems and design levels selected portfolio of projects that illustrate research institutes in the world. Focusing on as illustrated in our Discovery through the diversity, quality and dynamism of advanced quantitative approaches to specific Innovation Pipeline (fig 1.0). our research teams. Our reputation as an biotechnology challenges at the interface, international leader in the biotechnology We pursue and are actively engaged in the MIB enjoys a unique pluralistic and open field is evidenced with over 1400 Harnessing the synergy of interdisciplinarity challenging research projects that enable research culture that is realised through a publications, since 2009, in major journals us to make significant advances in science Focusing on specific challenges in biotechnology the co localisation of researchers from distinct coherent and integrated research concept and the impact of the Institute’s research is and engineering to benefit industry disciplines generates interdisciplinary teams with unique capabilities. and the establishment of a unique multi- and evident from a sustained commitment to the and society. Our track record in driving inter-disciplinary community of researchers successful translation of basic science into major interdisciplinary programmes in commercial success. committed to working across discipline Design promotes interaction biotechnology has attracted more than boundaries. The Manchester Institute of £90M in external funding since MIB’s As a leading industry-interfaced Reflecting the needs of interdisciplinary science, the MIB features open-plan, multifunctional Biotechnology is committed to inception in 2006 and our portfolio biotechnology institute we are proud to laboratories and extensive specialist research facilities. The MIB is based at the John Garside the pursuit of research excellence, continues to grow substantially primarily engage in technology transfers and have Building and houses over 500 research staff education, knowledge transfer through a ‘tightening’ of our focus in areas a number of strategic partnerships with and students from 52 research groups from Discovery through innovation and discovery through innovation of core strength (industrial biotechnology; companies from the chemical, biotechnology across The University of Manchester from Delivering internationally recognised programmes across all disciplines, with a strong emphasis whereby a coherent and integrated synthetic biology; catalysis science; systems- and biopharmaceutical sectors to translate the Faculties of Engineering and Physical on translational research, knowledge transfer and discovery through innovation. interdisciplinary research community based research; biomedical biotechnology; research council funding into products and Sciences, Life Sciences, and Medical and work towards developing new fuels and energy research), and supported services for the betterment of all people and Human Sciences. With a strong emphasis on biotechnologies that will find by strategic recruitment to new leadership the environment across the globe. Innovation in action translational research, knowledge transfer applications in areas such as human positions in the Institute. and discovery through innovation our Nigel Scrutton Advancing economic and societal development through knowledge generation and transfer. health, the energy economy, food philosophy has placed us in a strong position Our research strengths are showcased in Director Enabling companies of all sizes to benefit from our research technology and expertise. security, industrial transformations and to address a series of Grand Challenges that the ensuing pages defining our research Exploiting commercially significant innovation through licensing and the creation of spin-out/spin-ins. the environment. 4 5 The University of Manchester Our goal, outlined in the Manchester 2020 quality of our research activity is unrivalled pioneering approaches to major global strategic plan, is to establish the University as in the UK. We have a distinguished history challenges in biotechnology it has evolved a major centre for interdisciplinary research. in research, innovation and enterprise into one of the leading biotechnology The large scale and quality of our activity at stretching back over 180 years with many of research institutes in the world. Manchester sets us apart. We are able to the major advances of the twentieth century We are committed to enhancing the lives combine disciplines and capabilities to meet having been discovered at the University. of all people, through knowledge transfer both the challenges of leading-edge research Our institutes carry responsibility for several and education and this commitment is and the external demands of society, of the University’s key research priorities, firmly embedded in the global challenges business and other stakeholders. working in areas where we have achieved that constitute the unique research vision The University of Manchester is one of or aspire to world-leading status. The of the MIB whose role is integral to the the world’s leading centres for biomedical Manchester Institute of Biotechnology was advancement of the research mission of the and biotechnology research that sits at the the first university-based, purpose-built University. forefront of new discoveries in science and interdisciplinary research institute of its kind Professor Luke Georghiou engineering. Research is at the heart of the in the UK. Through the establishment of Vice President for Research University and the sheer scale, diversity and multi-skilled interdisciplinary teams applying Expanding cross campus in spectroscopy through Professor Peter In a programme funded by the EPSRC the MIB collaboration Gardner. Our systems/modelling/text mining engaged in a suite of short-term speculative of modern cell sorters the relatively small on the design of these filter stages, and activities continue to assemble cross-faculty activities to consolidate the cross-disciplinary Stem cell fractionation using numbers obtained and the addition of use cutting edge science and technology We continue to develop collaborations across teams of researchers to deliver innovative culture within the Institute. In one project, interactions with artificial matrices labelling reagents mean that these methods to generate a completely new approach to the University campus with current research research at the forefront of medical Professor Peter Gardner in collaboration with There has been a recent explosion in interest are not suitable for widespread application of stem cell purification. Specialist techniques grant funding aligned with 83 research biotechnology. Professor Mark Dunne (FLS) differentiated four in and potential applications of stem cells. stem cell therapy. Stem cells have yet to find such as microfluidics, nanotechnology, rapid groups from all four Faculties. Recent separate cell lines in pancreatic stem cells using Their potential for therapeutic medical global application, because of their rarity. This microstructure prototyping will be combined funding successes and applications endorse FTIR cell population imaging technologies. applications is particularly exciting, with project proposes to change the current stem with the latest ideas in cell biochemistry a closer alliance with other University of Cross-disciplinary feasibility the real prospect of growing replacement Manchester Institutes: Photon Science Following on from earlier work led by cell sorting methods from low throughput and cell biorecognition to fulfil the primary tissue and bone to overcome a wide variety Institute, Manchester Institute of Innovation There are numerous areas of research within Professor John Vickerman which utilised one-by-one techniques to very high objective of making it easier, cheaper and of disease conditions. Stem cells also have Research, and the Institute for Science, the biological and biomedical field that imaging Mass Spectrometry for 2D and 3D throughput alternatives that will be capable faster to harvest useful stem cells. The benefit an important role in diagnostics, and have Ethics and Innovation. The development of require the ability to quantitatively analyse cellular characterisation in an Alzheimer’s of sorting millions of cells simultaneously.
Recommended publications
  • Metabolic Footprinting and Systems Biology: the Medium Is the Message
    Nature Reviews Microbiology | AOP, published online 10 June 2005; doi:10.1038/nrmicro1177 REVIEWS METABOLIC FOOTPRINTING AND SYSTEMS BIOLOGY: THE MEDIUM IS THE MESSAGE Douglas B. Kell*, Marie Brown*, Hazel M. Davey‡, Warwick B. Dunn*, Irena Spasic* and Stephen G. Oliver§ Abstract | One element of classical systems analysis treats a system as a black or grey box, the inner structure and behaviour of which can be analysed and modelled by varying an internal or external condition, probing it from outside and studying the effect of the variation on the external observables. The result is an understanding of the inner make-up and workings of the system. The equivalent of this in biology is to observe what a cell or system excretes under controlled conditions — the ‘metabolic footprint’ or exometabolome — as this is readily and accurately measurable. Here, we review the principles, experimental approaches and scientific outcomes that have been obtained with this useful and convenient strategy. The METABOLOME is defined as the quantitative comple- either the transcriptome or proteome. This is because ment of low-molecular-weight metabolites present in the activities of metabolic pathways are reflected a cell under a given set of physiological conditions1–9. more accurately in the concentrations of pools of It lends itself readily to functional genomic and other metabolites than in the concentrations of the relevant analyses, as changes in a cell’s physiology as a result of enzymes (or indeed the concentrations of the mRNAs gene deletion or overexpression are amplified through encoding them). the hierarchy of the TRANSCRIPTOME and the PROTEOME, Metabolomics is therefore considered to be, in *School of Chemistry, and are therefore more easily measurable through the many senses, more ‘useful’ (that is, ‘discriminatory’) University of Manchester, metabolome, even when changes in metabolic fluxes than transcriptomics and proteomics, for the following Faraday Building, are negligible1,10–12.
    [Show full text]
  • Quantum Biology: an Update and Perspective
    quantum reports Review Quantum Biology: An Update and Perspective Youngchan Kim 1,2,3 , Federico Bertagna 1,4, Edeline M. D’Souza 1,2, Derren J. Heyes 5 , Linus O. Johannissen 5 , Eveliny T. Nery 1,2 , Antonio Pantelias 1,2 , Alejandro Sanchez-Pedreño Jimenez 1,2 , Louie Slocombe 1,6 , Michael G. Spencer 1,3 , Jim Al-Khalili 1,6 , Gregory S. Engel 7 , Sam Hay 5 , Suzanne M. Hingley-Wilson 2, Kamalan Jeevaratnam 4, Alex R. Jones 8 , Daniel R. Kattnig 9 , Rebecca Lewis 4 , Marco Sacchi 10 , Nigel S. Scrutton 5 , S. Ravi P. Silva 3 and Johnjoe McFadden 1,2,* 1 Leverhulme Quantum Biology Doctoral Training Centre, University of Surrey, Guildford GU2 7XH, UK; [email protected] (Y.K.); [email protected] (F.B.); e.d’[email protected] (E.M.D.); [email protected] (E.T.N.); [email protected] (A.P.); [email protected] (A.S.-P.J.); [email protected] (L.S.); [email protected] (M.G.S.); [email protected] (J.A.-K.) 2 Department of Microbial and Cellular Sciences, School of Bioscience and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK; [email protected] 3 Advanced Technology Institute, University of Surrey, Guildford GU2 7XH, UK; [email protected] 4 School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK; [email protected] (K.J.); [email protected] (R.L.) 5 Manchester Institute of Biotechnology, Department of Chemistry, The University of Manchester,
    [Show full text]
  • Catalysishub NEWSLETTER
    CatalysisHub NEWSLETTER The UK Catalysis Hub has created a thriving and successful network of catalytic scientists who are developing and promoting catalytic science in the UK. The Hub has succeeded in coordinating the community and is contributing to the development of new approaches and techniques in the field. It has provided substantial added value and is now recognised widely both in the UK and internationally. It will provide an excellent base for the future development of this crucial area of science in the UK. “The Hub has demonstrated resilience in the current pandemic with the community coming together to support each other through webinars and training courses and we will continue these in more normal times. Our proposal round was very successful with a large number of high quality proposals submitted and we have funded an excellent portfolio of research. The next few months will hopefully see an easing of the lockdown and an increase in our ability to do research. We hope that all are keeping well and safe and we look forward to meeting in person when we can and discussing catalytic research face to face.” ~ Professor Christopher Hardacre, Director Events Highlights of 2020 online via our website, so they will be a future resource for the whole catalysis community. COVID-19 has had a major impact on scientific network and dissemination due to travel UKCC 2020, 7 - 9 January 2020 restrictions and social distancing making face to face meetings and conferences unfeasible. The UK Catalysis Hub winter conference was held virtually and we worked on a vibrant programme of webinars, scientific discussions and other online events.
    [Show full text]
  • Innovation Academy Symposium Brochure
    Stretch & Hold Forth Innovation Academy 7th December 2018 Innovation Academy Programme INTRODUCTION 9.15 Registration 9.45 Welcome Joy Milne ‘NOSE’ MORNING SESSION Chair - Rob Dunn 10.00 Prof Perdita Barran Nose to Diagnose – The search for volatile biomarkers of Parkinson disease in sebum 10.30 Dr Meera Chand Application of nanopore technology 11.00 Olivier Usher – Nesta Flying High 11.30 BREAK Chair – Prof Neil Dalton 11.55 Prof Hal Drakesmith - University of Oxford The importance of being iron-ic 12.15 Prof Josephine Bunch – National Physical Laboratory The Google earth of cancer 12.45 Panel Discussion 1.00 LUNCH Excellence in Pathology – 2018 finalists and voting 2.00 Terry Hunter Quantitative assessment of NFKB transcription factor activity in health and disease 2.05 Younis Khan Luminex-based detection of complement-fixing antibodies using HLA antigens isolated from donor cells – An alternative to the CDC crossmatch 2.10 Rachel Mayhew Functional characterisation of genetic variants using red blood cell ektacytometry AFTERNOON SESSION Chair – Alan Dunlop 2.15 Marie-Jose Weber – PRUH OSNA at the PRUH 2.45 Dr Sally Brady, Karolina Witek, Erin Emmett An introduction to analytical continuous quality improvement: 3 case studies 3.15 Dr Gary Moore - Viapath Viapath and Venom 3.45 Winner of Excellence in Pathology announced 4.00 CLOSE Innovation Academy Dr Dominic Harrington CHIEF SCIENTIFIC OFFICER, VIAPATH It gives me great pleasure to welcome you all to our eighth Innovation Academy Scientific Symposium, ‘Stretch & Hold Forth’. At our seventh symposium we focussed on the advances made in the provision of healthcare since the founding of the National Health Service 70 years ago.
    [Show full text]
  • Models of Biological Regulation
    Models of Biological Regulation by Moritz Emanuel Beber A thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Bioinformatics Approved Dissertation Committee: Prof. Dr. Marc-Thorsten Hütt (chair), Jacobs University Bremen Prof. Dr. Georgi Muskhelishvili, Jacobs University Bremen Prof. Dr.-Ing. Katja Windt, Jacobs University Bremen Prof. Dr. Stefan Bornholdt (external), Universität Bremen Date of Defense: April 17, 2015 Department of Life Sciences & Chemistry iii Statutory Declaration I, Moritz Emanuel Beber, hereby declare, under penalty of perjury, that I am aware of the consequences of a deliberately or negligently wrongly submitted affidavit, in particular the punitive provisions of § 156 and § 161 of the Criminal Code (up to 1 year imprisonment or a fine at delivering a negligent or 3 years or a fine at a knowingly false affidavit). Furthermore I declare that I have written this PhD thesis independently, unless where clearly stated otherwise. I have used only the sources, the data and the support that I have clearly mentioned. This PhD thesis has not been submitted for the conferral of a degree elsewhere. Bremen, July 11, 2017 .................................................................................. Moritz Beber iv Preface The following people deserve my sincerest thanks, more so than I can express in words. There are others whom I do not mention here but also deserve my thanks, please know that you are appreciated nonetheless. First and foremost, I thank my family for showing me, time and again, their unconditional love. Without you I simply would not be here! In particular, I thank my mother Katinka and father Thomas for being calm and analytical when I needed them to but otherwise placing their complete trust in me to go my own way.
    [Show full text]
  • 8Th Conference AM.Pdf
    Measuring the interplay between uptake and loss processes of xenobiotics 13th June 2019 Maddalena Bronzato Physical Chemistry Chemical Technologies & Operations Group Chemical Research, Jealott’s Hill Understanding losses from a foliar surface Volatilisation 2 Why is pesticide volatility so important? ● Environmental fate (loss and persistence) ● Registrability ● Activity (vapour activity and volatility as a benefit) Vapour activity on Aphids Powdery mildew on Fruit Environmental fate 3 Understanding losses from a foliar surface Volatilisation Photodegradation 4 Why is pesticide photodegradation important? ● Activity (photodegradation is one of most destructive post-application pathways) ● Environmental fate (product and persistence) ● Marketability ● Registrability Pesticide sprayed on leaf surface 5 In lab test for volatility and photodegradation Photodegradation Suntest Volatilisation Wind Tunnel 6 Testing for photodegradation - Suntest ● Atlas XLS+ Suntest ● UV-filtered xenon lamp ● Mimics sunlight intensity & spectrum ● Irradiance set to 750W/m2 ● Thermostated baseplate (circulating water @ 15ºC → baseplate ≈ 20 ± 3ºC) 7 Test for volatility- The Wind Tunnel ● Very sample-efficient means of estimating vapour pressure (typically <100µg)] ● Studies are normally run at 40C with a standard wind speed of 1m/s (no control of the R.H.) 8 Photodegradation and volatility test – glass as substrate Pros: ● Good proxy for foliar surface ● Uniform, clean substrate to use for the tests ● High-throughput test ● Worst case scenario ● Indicative but imperfect Limitations: ● Different polarity and morphology between glass and leaves–> differences in redistribution mechanism and deposit shape? 9 SEM images of leaf and glass surfaces Glass 10 Surface redistribution mechanisms Volatilisation Photodegradation Vapour Phase Redistribution 11 Different deposit – effect on photodegradation and volatility Crystalline Amorphous A highly crystalline deposit The larger the deposit area, the faster the compound volatilises.
    [Show full text]
  • Synthetic Biology
    From Molecular Biology to Synthetic Biology, what’s new? Sandra Taylor, Senior Research Technician, BSc (Hons), Mphil, Rsci, MIScT [email protected] (0161) 306 5131 Small beginnings in Norwich, after my first degree • 1987 - First lab job veterinary tests: Bacteriology, post mortems, blood, urine, faeces tests etc. Plant Molecular Genetics 1988 to 1998 – the lab grew from 6 to 16 people and several papers were published on the way that flowering is controlled. 1998 to 2001: Biochemistry Division, School of Biological Sciences, Manchester University – I supported 6 research groups, sharing expertise. Topics from cell division (in toads) to asthma (in horses and people), and cultured human cells. Career Break from 2001 to 2007 • Starting again after 6 years was a challenge but I soon got back up to speed. Technical roles are very varied, never boring, a bit like being a Mum! 2007 to present • I spent 7 years in the Michael Smith Building (Life Sciences) – various roles (cell culture, cloning, yeast two-hybrid) • In 2014 I moved to the MIB – more Chemistry/Biochemistry focussed Nano-scale 3D printing?! Micro-titre plates with 96, 384 or even 1536 sample wells – technology is being developed to “write” strings of DNA into these tiny wells using 3D nano-printing technology. Present Challenges Supporting SYNBIOCHEM • New subject(s) and equipment to learn about • The new SYMBIOCHEM team is 10 people and 4 robots! • IT technology means writing electronic lab notebooks instead of paper ones! • The new team is multidisciplinary so lots to learn but good fun! • This is now the age of writing DNA, as opposed to just reading it Publications (please note publications I contributed prior to 2006 were under my maiden name of Doyle) Structural Basis for Specific Interaction of TGFβ Signaling Regulators SARA/Endofin with HD-PTP.
    [Show full text]
  • The Implementation of Open Access Oral and Written Evidence Contents 1994 Group – Written Evidence
    SCIENCE AND TECHNOLOGY SELECT COMMITTEE The implementation of open access Oral and Written evidence Contents 1994 Group – Written evidence ............................................................................................................. 5 Academy of Social Sciences – Written evidence ................................................................................. 8 Association for Learning Technology (ALT) – Written evidence ................................................. 13 Association of Learned and Professional Society Publishers (ALPSP) – Written evidence .... 19 Jeffrey Beall, Scholarly Initiatives Librarian, University of Colorado Denver – Written evidence ...................................................................................................................................................... 24 Dr Rick Bradford – Written evidence ................................................................................................ 25 British Academy – Written evidence .................................................................................................. 27 British Heart Foundation (BHF) – Written evidence ...................................................................... 32 British Medical Journal Group (BMJ) – Written evidence .............................................................. 34 British Psychological Society (BPS) – Written evidence ................................................................. 38 British Sociological Association (BSA) – Written evidence...........................................................
    [Show full text]
  • Scientists a Step Closer to Developing Renewable Propane 10 April 2015
    Scientists a step closer to developing renewable propane 10 April 2015 change. Efforts to find cleaner, more sustainable forms of energy as well as using biotechnology techniques to produce synthetic chemicals are currently being developed at The University of Manchester." Natural metabolic pathways for the renewable biosynthesis of propane do not exist but scientists at the University have developed an alternative microbial biosynthetic pathway to produce renewable propane. The team led by Nigel Scrutton and Dr Patrik Jones from Imperial College, modified existing fermentative butanol pathways using an engineered enzyme variant to redirect the microbial pathway to produce propane as opposed to butanol. The team was able to achieve propane biosynthesis creating a platform for next-generation microbial propane production. Researchers at The University of Manchester have Propane has very good physicochemical properties made a significant breakthrough in the which allow it to be stored and transported in a development of synthetic pathways that will enable compressed liquid form. While under ambient renewable biosynthesis of the gas propane. This conditions it is a clean-burning gas, with existing research is part of a programme of work aimed at global markets and infrastructure for storage, developing the next generation of biofuels. distribution and utilization in a wide range of applications ranging from heating to transport fuel. This study provides new insight and understanding Consequently, propane is an attractive target of the development of next-generation biofuels. In product in research aimed at developing new this latest study, published in the journal renewable alternatives to complement currently Biotechnology for Biofuels, scientists at the used petroleum-derived fuels.
    [Show full text]
  • Download Download
    Journal of Artificial Intelligence Research 32 (2008) 825{877 Submitted 06/07; published 08/08 Qualitative System Identification from Imperfect Data George M. Coghill [email protected] School of Natural and Computing Sciences University of Aberdeen, Aberdeen, AB24 3UE. UK. Ashwin Srinivasan [email protected] IBM India Research Laboratory 4, Block C, Institutional Area Vasant Kunj Phase II, New Delhi 110070, India. and Department of CSE and Centre for Health Informatics University of New South Wales, Kensington Sydney, Australia. Ross D. King [email protected] Deptartment of Computer Science University of Wales, Aberystwyth, SY23 3DB. UK. Abstract Experience in the physical sciences suggests that the only realistic means of under- standing complex systems is through the use of mathematical models. Typically, this has come to mean the identification of quantitative models expressed as differential equations. Quantitative modelling works best when the structure of the model (i.e., the form of the equations) is known; and the primary concern is one of estimating the values of the param- eters in the model. For complex biological systems, the model-structure is rarely known and the modeler has to deal with both model-identification and parameter-estimation. In this paper we are concerned with providing automated assistance to the first of these prob- lems. Specifically, we examine the identification by machine of the structural relationships between experimentally observed variables. These relationship will be expressed in the form of qualitative abstractions of a quantitative model. Such qualitative models may not only provide clues to the precise quantitative model, but also assist in understand- ing the essence of that model.
    [Show full text]
  • Rebecca Darley, Daniel Reynolds and Chris Wickham Open Access Journals in Humanities and Social Science a British Academy Research Project
    OPEN ACCESS JOURNALS IN HUMANITIES AND SOCIAL SCIENCE Rebecca Darley, Daniel Reynolds and Chris Wickham Open access journals in Humanities and Social Science A British Academy Research Project Rebecca Darley, Daniel Reynolds and Chris Wickham The British Academy 2014 THE BRITISH ACADEMY 10–11 Carlton House Terrace London SW1Y 5AH Website: www.britac.ac.uk Registered Charity, No. 233176 © 2014 the contributors This text is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. ISBN 978-0-85672-614-9 Contents Open access journals in Humanities and Social Science: summary 4 1. Introduction and context 10 2. UK Humanities and Social Science journal publishing and its international face 24 3. The open access policies of journals outside the UK 36 4. Journal half-lives and their implications 49 5. The viability of journals in an open-access context 67 6. Who should pay for publishing? 78 7. Conclusions 88 Appendix A 95 Appendix B 100 Appendix C 103 4 Open access journals in Humanities and Social Science Open access journals in Humanities and Social Science: summary Open access journals in Humanities and Social Science, published 2014 by the British Academy Open access journals in Humanities and Social Science: summary 5 Introduction • This British Academy research project on the effects of current UK open access policies was funded by the Higher Education Funding Council for England (HEFCE) and was overseen by a Steering Committee set up by the Academy to manage the project. The project was led by Professor Chris Wickham, FBA (British Academy Vice-President, Publications), with support and co-writing from Dr Rebecca Darley and Dr Daniel Reynolds.
    [Show full text]
  • Proteins: from Chemical to Physiological Mechanism 26 October 2001
    Meeting report report Proteins: from Chemical to Physiological Mechanism 26 October 2001 The Molecular Enzymology Group of the Biochemical Society by David Trentham held a special 1-day meeting at the Royal Society on ‘Proteins: (National Institute of Medical from Chemical to Physiological Mechanism’.The aim of the Research, Mill Hill) and Downloaded from http://portlandpress.com/biochemist/article-pdf/24/3/31/3597/bio024030031.pdf by guest on 01 October 2021 meeting was to inform and stimulate discussion on kinetic Michael Greeves approaches to the life sciences by bringing together work on (University of Kent) dynamic aspects of protein function.The meeting also honoured Professor H. (Freddie) Gutfreund, FRS, on his 80th birthday. Professor Gutfreund persuaded the Executive Committee of the Society to found the Molecular Enzymology Group, the first sub-group of the Society. His view of the strategic value in Professor Freddie encouraging like-minded biochemists to interact has done much to Gutfreund during his provide the critical mass necessary for sustaining excellence in the presentation ‘Development various sub-disciplines of biochemistry. of kinetics in biology’. The talks reflected Professor about how proteins function. and his family. The dinner was Gutfreund’s many contributions In particular, he has made major followed by entertaining and to the study of biochemistry and contributions to the development affectionate talks presented biophysics. His early prominence of transient and relaxation kinetic by Nigel Scrutton, the present arose from developing the method- methods including stopped-flow, Chairman of the Molecular Speakers and Chairmen: ology to study fast events on quenched-flow and pressure- Enzymology Group, Hugh Back row (from left to enzymes which are now central to jump techniques.
    [Show full text]